These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Lupus erythematosus disseminatus and active isoniazid levels. A study of 47 cases]. Godeau P; Aubert M; Imbert JC; Herreman G Ann Med Interne (Paris); 1973 Mar; 124(3):181-6. PubMed ID: 4716710 [No Abstract] [Full Text] [Related]
6. Use of sulphadimidine acetylation test in determining isoniazid inactivation rate in tuberculous patients. Sen PK; Chatterjee R; Saha JR Indian J Med Res; 1972 Jan; 60(1):28-39. PubMed ID: 5029122 [No Abstract] [Full Text] [Related]
7. Isoniazid inactivation in Finns and Lapps as demonstrated by various methods. Tittinen H; Mattila MJ; Eriksson AW Am Rev Respir Dis; 1973 Aug; 108(2):375-8. PubMed ID: 4720700 [No Abstract] [Full Text] [Related]
8. [Pharmacokinetics of isoniazid in aged subjects]. Kergueris MF; Bourin M; Le Normand Y; Larousse C; Rembeaux A Therapie; 1986; 41(1):19-22. PubMed ID: 3704989 [No Abstract] [Full Text] [Related]
9. Possible chloroquine-induced modification of N-acetylation of isoniazid and sulphadimidine in the rat. Nwankwo JO; Garba MA; Chinje CE; Mgbojikwe LO; Emerole GO Biochem Pharmacol; 1990 Aug; 40(3):654-9. PubMed ID: 2383293 [No Abstract] [Full Text] [Related]
10. [Acetylation phenotype of isoniazid in Morocco. Preliminary study of 100 cases]. Bouayad Z; Chevalier B; Maurin R; Bartal M Rev Fr Mal Respir; 1982; 10(6):401-7. PubMed ID: 7163595 [TBL] [Abstract][Full Text] [Related]
11. A study of the availability of six commercial formulations of isoniazid. Gelber R; Jacobsen P; Levy L Clin Pharmacol Ther; 1969; 10(6):841-8. PubMed ID: 5349625 [No Abstract] [Full Text] [Related]
12. [Isoniazid acetylation in hepatic cirrhosis]. Pereira Filho RA; Sevá-Pereira A; de Magalhães AF; Ramalho AS Rev Paul Med; 1985; 103(6):276-9. PubMed ID: 3841966 [No Abstract] [Full Text] [Related]
14. Simplified screening test for phenotyping of isoniazid inactivators. Eidus L; Hodgkin MM Int J Clin Pharmacol; 1973 Feb; 7(1):82-6. PubMed ID: 4699389 [No Abstract] [Full Text] [Related]
15. Classification of subjects as slow or rapid inactivators of isoniazid, based on the ratio of the urinary excretion of acetylisoniazid to isoniazid. Venkataraman P; Menon NK; Nair NG; Radhakrishna S; Ross C; Tripathy SP Indian J Med Res; 1972 May; 60(5):685-93. PubMed ID: 4663236 [No Abstract] [Full Text] [Related]
16. [A comparative study of free isoniazid levels in the serum by microbiological estimation and a new chemical method (author's transl)]. Bergogne-Berezin E; Conso F; Gaultier M; Pollet J; Courtoux D Pathol Biol (Paris); 1976 Oct; 24(8):537-43. PubMed ID: 10543 [No Abstract] [Full Text] [Related]
18. The determination of the acetylator phenotype of tuberculosis patients in Czechoslovakia using sulphadimidine. Víznerová A; Slavíková Z; Ellard GA Tubercle; 1973 Mar; 54(1):67-71. PubMed ID: 4774936 [No Abstract] [Full Text] [Related]
19. [Preliminary study of the phenotype for acetylation in Teribe Amerindians]. Arias TD; Jorge LF; Núñez G; Inaba T Rev Med Panama; 1987 Jan; 12(1):30-6. PubMed ID: 3589006 [No Abstract] [Full Text] [Related]
20. Determination of isoniazid and metabolites in biological fluids. Boxenbaum HG; Riegelman S J Pharm Sci; 1974 Aug; 63(8):1191-7. PubMed ID: 4851320 [No Abstract] [Full Text] [Related] [Next] [New Search]